A Turning Point for Federal Cannabis Policy

On August 11, 2025, President Donald Trump confirmed that his administration is actively reviewing the federal classification of cannabis and may move it from Schedule I—the category reserved for substances deemed to have “no accepted medical use”—to Schedule III. Speaking at a White House press briefing, Trump described the decision as “close” and promised clarity “within the coming weeks.”

If enacted, this would be the most significant federal cannabis reform in U.S. history, reshaping tax laws, research access, and business expansion potential overnight.

What Reclassification to Schedule III Would Mean

Cannabis is currently listed alongside heroin and LSD under Schedule I of the Controlled Substances Act, creating enormous hurdles for the legal cannabis market—even in states where it’s permitted for medical or adult use.

Shifting it to Schedule III would:

  • Ease Criminal Penalties – Reducing federal sentencing severity for cannabis-related offenses.
  • Unlock Business Deductions – Eliminating the burdens of IRS Code 280E, allowing cannabis operators to deduct standard business expenses like rent, payroll, and marketing.
  • Accelerate Research – Making it easier for universities, biotech companies, and medical researchers to study cannabis without navigating excessive DEA barriers.
  • Encourage Banking Access – Opening pathways for more banks to work with cannabis companies without fear of federal repercussions.
  • Set the Stage for Interstate Commerce – While not immediate, this could lay groundwork for legal cannabis crossing state lines.

The Market Reacts

Within hours of Trump’s announcement, cannabis-related stocks surged. Companies like Tilray Brands, Canopy Growth, and Village Farms International saw double-digit percentage gains, and the U.S.-focused AdvisorShares Pure U.S. Cannabis ETF (MSOS) jumped significantly.

Investor optimism stems from the fact that Schedule III status would make the legal cannabis market more profitable, less risky, and more attractive for institutional investment.

Industry Voices Respond

Leaders in the cannabis industry reacted quickly to the news:

  • Advocacy Groups: Organizations like the National Cannabis Industry Association praised the move as “a critical first step toward rational cannabis policy.”
  • Small Business Owners: Independent dispensary operators voiced hope that tax relief would make it easier to compete with large multi-state operators.
  • Medical Professionals: Researchers welcomed the prospect of reduced barriers to studying cannabis for pain, PTSD, and other conditions.

However, some advocates argue that while Schedule III would be progress, full descheduling is the only way to truly normalize cannabis and address decades of prohibition-related harm.

Political Context

Previous administrations, including Joe Biden’s, expressed interest in cannabis reform but failed to enact a meaningful federal change. Trump’s latest comments mark a rare moment of bipartisan alignment—with lawmakers from both parties voicing support for rescheduling or legalization.

The move is also seen as a political play to energize younger voters and independents ahead of the 2026 midterm elections.

What Happens Next

Reclassification would require action from the U.S. Department of Justice and DEA, both of which are reportedly reviewing recommendations from the Department of Health and Human Services (HHS). If approved, the rulemaking process could begin this fall, with formal implementation in 2026.

Until then, cannabis remains federally illegal, and all state-licensed businesses must continue complying with existing state laws and tracking systems like METRC or BioTrack.

How Cannabis Businesses Should Prepare Now

Even before any formal change, operators can take proactive steps:

  1. Assess Tax Strategy: Work with a CPA experienced in cannabis to model post-280E profitability.
  2. Expand Banking Relationships: Begin discussions with financial institutions that have cannabis-compliant programs.
  3. Position for Expansion: Explore partnerships in other states to capitalize quickly if interstate trade becomes viable.
  4. Increase Compliance Rigor: Federal scrutiny will remain high during the transition; clean recordkeeping is critical.